Biofourmis

Biofourmis

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $470M

Overview

Biofourmis is a private, revenue-generating digital health platform company leveraging AI and machine learning to enable hospital-at-home, remote patient management, and clinical trial support. Its core offering is a technology platform that uses biosensor data and predictive analytics to improve patient outcomes, reduce costs, and support drug development. The company has over 50 global health system and payer partners, operates in 25 U.S. states, and recently merged with CopilotIQ to create an end-to-end AI-driven in-home care platform, while divesting its life science business to ActiGraph.

AI / Machine Learning

Technology Platform

A connected technology platform that uses wearable biosensors and AI/machine learning algorithms for remote patient monitoring, predictive analytics, and personalized care management across care settings.

Funding History

4
Total raised:$470M
Series D$300M
Series C$100M
Series B$35M
Series A$35M

Opportunities

The strong macro shift towards value-based care and hospital-at-home models, accelerated by CMS waivers, presents a massive expansion opportunity.
The merger with CopilotIQ allows Biofourmis to offer a unique end-to-end solution, potentially capturing more value per patient and differentiating from pure-play software competitors.

Risk Factors

Key risks include dependence on volatile healthcare reimbursement policies, intense competition in the digital health platform space, and the operational complexity of integrating AI technology with clinical workflows across diverse health system partners.

Competitive Landscape

Biofourmis competes in the crowded digital health and remote patient monitoring market against players like Current Health (acquired by Best Buy), Philips, Medtronic, and numerous startups. Its merger with CopilotIQ positions it against integrated providers like Contessa Health (a CVS Health company) and Signify Health, competing on the basis of its AI-driven predictive analytics platform combined with in-home clinical services.